SCHEMBL23045682

SCHEMBL23045682

CCOC(=O)c1cc2cc(N)ccc2n1CCOC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
GAA P10253 1/20 0.49
TSHR P16473 1/20 0.49
HSD17B10 Q99714 1/20 0.49
CRHBP P24387 1/20 0.49
CRHR2 Q13324 1/20 0.49
NOD2 Q9HC29 1/20 0.46
NOD1 Q9Y239 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
ADORA3 P0DMS8 2/20 0.43
F10 P00742 2/20 0.43
CACNA1B Q00975 1/20 0.43
PTGER4 P35408 1/20 0.42
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29463272 1.00 KDM4E (0.49) KDM4ESMN1; SMN2GAATSHRHSD17B10
SCHEMBL23045656 0.93 KDM4E (0.47) KDM4ESMN1; SMN2GAATSHRHSD17B10
SCHEMBL29463264 0.93 KDM4E (0.47) KDM4ESMN1; SMN2GAATSHRHSD17B10
SCHEMBL31383524 0.89 KDM4E (0.52) KDM4ESMN1; SMN2TSHRHSD17B10CRHBP
SCHEMBL23045603 0.89 KDM4E (0.52) KDM4ESMN1; SMN2TSHRHSD17B10CRHBP
SCHEMBL23045587 0.88 NOD2 (0.47) KDM4ESMN1; SMN2TSHRHSD17B10CRHBP
SCHEMBL29463233 0.88 NOD2 (0.47) KDM4ESMN1; SMN2TSHRHSD17B10CRHBP
SCHEMBL31383507 0.86 KDM4E (0.50) KDM4ESMN1; SMN2GAATSHRCRHBP
SCHEMBL23045589 0.86 KDM4E (0.50) KDM4ESMN1; SMN2GAATSHRCRHBP
SCHEMBL16733085 0.86 KDM4E (0.50) KDM4ESMN1; SMN2GAATSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12465588-B2 Indole carboxamide derivative and pharmaceutical composition containing same KUKJE PHARMA CO., LTD. (KR) 2025-11-11 US disclosed
US-20230000821-A1 INDOLE CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME KUKJE PHARMA CO., LTD. (KR) 2023-01-05 US disclosed
EP-4023638-A1 INDOLE CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME Kukje Pharma Co., Ltd. (KR) 2022-07-06 EP disclosed
CN-114302874-A Indole carboxamide derivatives and pharmaceutical compositions comprising same 国际药品株式会社 2022-04-08 CN disclosed
WO-2021040393-A1 INDOLE CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME 국제약품 주식회사 2021-03-04 WO disclosed
WO-2021040393-A1 INDOLE CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME 국제약품 주식회사 2021-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12465588-B2 Indole carboxamide derivative and pharmaceutical composition containing same PTGES, PTGES2, PTGS1 KDM4E 2460/4885SMN1; SMN2 1986/4885GAA 3653/4885
US-20230000821-A1 INDOLE CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME PTGES, PTGES2, PTGS1 KDM4E 2460/4885SMN1; SMN2 1986/4885GAA 3653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.